FGF21 and metabolic dysfunction-associated steatohepatitis: Population with abnormal levels of CK-18-M30, FGF-21, IL-1Ra, PEDF and OPG seemed more possible to suffer from NASH, indicating these biomarkers have a crucial place in NASH prediction.